Supervision of Facilitators in a Multisite Study: Goals, Process, and Outcomes Wu Elwin contributor Columbia University. Social Work Witte Susan S. contributor Columbia University. Social Work El-Bassel Nabila contributor Columbia University. Social Work Gilbert Louisa contributor Columbia University. Social Work NIMH Multisite HIV/STD Prevention Trial for African American Couples Group author Columbia University. Social Work originator text Articles 2008 manuscript version English Objective: To describe the aims, implementation, and desired outcomes of facilitator supervision for both interventions (treatment and control) in Project Eban and to present the Eban Theoretical Framework for Supervision that guided the facilitators’ supervision. The qualifications and training of supervisors and facilitators are also described. Design: This article provides a detailed description of supervision in a multisite behavioral intervention trial. The Eban Theoretical Framework for Supervision is guided by 3 theories: cognitive behavior therapy, the Life-long Model of Supervision, and "Empowering supervisees to empower others: a culturally responsive supervision model." Methods: Supervision is based on the Eban Theoretical Framework for Supervision, which provides guidelines for implementing both interventions using goals, process, and outcomes. Results: Because of effective supervision, the interventions were implemented with fidelity to the protocol and were standard across the multiple sites. Conclusions: Supervision of facilitators is a crucial aspect of multisite intervention research quality assurance. It provides them with expert advice, optimizes the effectiveness of facilitators, and increases adherence to the protocol across multiple sites. Based on the experience in this trial, some of the challenges that arise when conducting a multisite randomized control trial and how they can be handled by implementing the Eban Theoretical Framework for Supervision are described. Behavioral sciences Public health Journal of Acquired Immune Deficiency Syndromes 49 Supplement 1 S59 S67 2008-09-01 http://dx.doi.org/10.1097/QAI.0b013e3181844807 1525-4135 http://hdl.handle.net/10022/AC:P:14282 NNC NNC 2012-07-30 15:53:28 -0400 2013-05-03 16:38:13 -0400 8289 eng